New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage

被引：90

作者：

Crowley, R. Webster ^{[1
]}

Medel, Ricky ^{[1
]}

Kassell, Neal F. ^{[1
]}

Dumont, Aaron S. ^{[1
]}

机构：

[1] Univ Virginia, Sch Med, Dept Neurol Surg, Charlottesville, VA 22908 USA

来源：

DRUG DISCOVERY TODAY | 2008年 / 13卷 / 5-6期

关键词：

D O I：

10.1016/j.drudis.2007.11.010

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cerebral vasospasm lingers as the leading preventable cause of death and disability in patients who experience aneurysmal subarachnoid hemorrhage. Despite the potentially devastating consequences of cerebral vasospasm, the mechanisms behind it are incompletely understood. Nitric oxide, endothelin-1, bilirubin oxidation products and inflammation appear to figure prominently in its pathogenesis. Therapies directed at many of these mechanisms are currently under investigation and hold significant promise for an ultimate solution to this substantial problem.

引用

页码：254 / 260

页数：7

共 85 条

[1] Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage [J].

Alafaci, C ;

Salpietro, F ;

Grasso, G ;

Sfacteria, A ;

Passalacqua, M ;

Morabito, A ;

Tripodo, E ;

Calapai, G ;

Buemi, M ;

Tomasello, F .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (02) :219-225

[2] CEREBRAL ARTERIAL SPASM - A CONTROLLED TRIAL OF NIMODIPINE IN PATIENTS WITH SUBARACHNOID HEMORRHAGE [J].

ALLEN, GS ;

AHN, HS ;

PREZIOSI, TJ ;

BATTYE, R ;

BOONE, SC ;

CHOU, SN ;

KELLY, DL ;

WEIR, BK ;

CRABBE, RA ;

LAVIK, PJ ;

ROSENBLOOM, SB ;

DORSEY, FC ;

INGRAM, CR ;

MELLITS, DE ;

BERTSCH, LA ;

BOISVERT, DPJ ;

HUNDLEY, MB ;

JOHNSON, RK ;

STROM, JA ;

TRANSOU, CR .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (11) :619-624

[3] Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis [J].

Amin-Hanjani, S ;

Ogilvy, CS ;

Barker, FG .

NEUROSURGERY, 2004, 54 (02) :326-334

[4] Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A metaanalysis [J].

Barker, FG ;

Ogilvy, CS .

JOURNAL OF NEUROSURGERY, 1996, 84 (03) :405-414

[5] The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage [J].

Bejjani, GK ;

Bank, WO ;

Olan, WJ ;

Sekhar, LN .

NEUROSURGERY, 1998, 42 (05) :979-986

[6] Neutralizing antibody against interleukin-6 attenuates posthemorrhagic vasospasm in the rat femoral artery model [J].

Bowman, G ;

Dixit, S ;

Bonneau, RH ;

Chinchilli, VM ;

Cockroft, KM .

NEUROSURGERY, 2004, 54 (03) :719-725

[7] A novel inhibitor of inflammatory cytokine production (CNI-1493) reduces rodent post-hemorrhagic vasospasm [J].

Bowman, George ;

Bonneau, Robert H. ;

Chinchilli, Vernon M. ;

Tracey, Kevin J. ;

Cockroft, Kevin M. .

NEUROCRITICAL CARE, 2006, 5 (03) :222-229

[8] In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage [J].

Buemi, M ;

Grasso, G ;

Corica, F ;

Calapai, G ;

Salpietro, FM ;

Casuscelli, T ;

Sfacteria, A ;

Aloisi, C ;

Concetta, A ;

Sturiale, A ;

Frisina, N ;

Tomasello, F .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 392 (1-2) :31-34

[9] Endothelin receptor antagonists and cerebral vasospasm: An update [J].

Chow, M ;

Dumont, AS ;

Kassell, NF .

NEUROSURGERY, 2002, 51 (06) :1333-1341

[10] Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage [J].

Clark, Joseph F. ;

Sharp, Frank R. .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2006, 26 (10) :1223-1233

← 1 2 3 4 5 6 7 8 9 →